Latest Biozone Pharm (BZNE) Headlines Biozone

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Biozone Pharm (BZNE) Headlines

Biozone Pharmaceuticals Inc raises USD2.75m in strategic investment
M2 - Fri Jan 24, 5:47AM CST
Biotechnology company Biozone Pharmaceuticals Inc (OTC BB:BZNE) reported on Thursday the receipt of USD2.75m from eight accredited investors, including OPKO Health (NYSE MKT:OPK).

Biozone Receives Strategic Investment From OPKO Health, Inc
Marketwire - Thu Jan 23, 8:30AM CST
Biozone Pharmaceuticals, Inc. (OTCQB: BZNE) today announced that it has raised $2,750,000 from eight accredited investors including OPKO Health (NYSE MKT: OPK).

MusclePharm Corporation acquires BioZone Pharmaceuticals' assets
M2 - Tue Jan 07, 5:52AM CST
Sports nutrition company MusclePharm Corporation (OTCQB:MSLP) revealed on Monday the completion of the acquisition of essentially all assets of BioZone Pharmaceuticals Inc (OTCBB: BZNE) and its subsidiaries, for 1.2m shares of MusclePharm stock.

MusclePharm Completes Acquisition of Substantially All Assets of BioZone Pharmaceuticals
Marketwire - Mon Jan 06, 7:31AM CST
MusclePharm Corporation (OTCQB: MSLP), a leading international, award-winning sports nutrition company, today announced that it has completed the acquisition of essentially all assets of BioZone Pharmaceuticals, Inc. (OTCBB: BZNE) and its subsidiaries, for 1.2 million shares of MusclePharm stock.

Biozone Pharmaceuticals Inc closes merger with Cocrystal Discovery
M2 - Mon Jan 06, 5:01AM CST
OTC drug products company Biozone Pharmaceuticals Inc (OTCQB:BZNE) said on Friday that it has finalised its planned merger with Cocrystal Discovery Inc.

UPDATE: Biozone Completes Acquisition of Cocrystal Discovery and Begins Transformation to High Growth Biotech Company
Marketwire - Fri Jan 03, 8:42AM CST
Biozone Pharmaceuticals, Inc. (OTCQB: BZNE) today announced that it has finalized its planned merger with Cocrystal Discovery, Inc., a privately-held, biotechnology company developing antiviral therapeutics for human diseases. Cocrystal Discovery has previously received strategic investments from Teva Pharmaceuticals (NYSE: TEVA), Opko Health (NYSE MKT: OPK) and The Frost Group.

Biozone Completes Acquisition of Cocrystal Discovery and Begins Transformation to High Growth Biotech Company
Marketwire - Fri Jan 03, 7:00AM CST
Biozone Pharmaceuticals, Inc. (OTCQB: BZNE) today announced that it has finalized its planned merger with Cocrystal Discovery, Inc., a privately-held, biotechnology company developing antiviral therapeutics for human diseases. Cocrystal Discovery has previously received strategic investments from Teva Pharmaceuticals (NYSE: TEVA), Opko Health (NYSE MKT: OPK) and The Frost Group.

BioZone Pharmaceuticals, Inc. Completes Balance Sheet Enhancement
Marketwire - Tue Dec 24, 7:00AM CST
BioZone Pharmaceuticals, Inc. (OTCBB: BZNE) announced today that it has completed an enhancement of its balance sheet by eliminating remaining outstanding convertible notes. In the recent transaction, holders of convertible notes with approximately $2.5 million of principal and accrued interest exchanged their securities for shares of common stock. OPKO Health Inc. (NYSE: OPK), a principal shareholder of BioZone Pharmaceuticals and one of the note holders that converted its notes, expressed the view through its Chairman and CEO, Dr. Phillip Frost, that it is optimistic that the planned acquisition of Cocrystal Discovery will enhance shareholder value and enhance BioZone's future prospects as a high growth biotech company.

BioZone Pharmaceuticals, Inc. Enhances Balance Sheet
Marketwire - Mon Dec 02, 7:46AM CST
BioZone Pharmaceuticals, Inc. (OTCQB: BZNE) announced today that it has enhanced its balance sheet significantly by eliminating outstanding convertible preferred stock. In the recent transaction, holders of convertible preferred stock, with a stated value of $3.5 million and a 10% dividend, exchanged their securities for shares of common stock. Key holders expressed the view that the recently announced merger with Cocrystal Discovery, Inc. is a significant positive development for the Company.

Biozone Pharmaceuticals signs Letter of Intent to reverse merge with Cocrystal Discovery
M2 - Thu Nov 28, 4:44AM CST
Biozone Pharmaceuticals Inc (OTCBB:BZNE) announced on Wednesday its agreement to the terms and signed a Letter of Intent to merge with Cocrystal Discovery Inc, a biotechnology company developing antiviral therapeutics for human diseases.

Biozone Pharmaceuticals Announces Executed Letter of Intent to Merge With Cocrystal Discovery Inc.
Marketwire - Wed Nov 27, 7:00AM CST
Biozone Pharmaceuticals, Inc. (OTCBB: BZNE) today announced that it has agreed to terms and signed a Letter of Intent to merge with Cocrystal Discovery, Inc., a privately-held, biotechnology company developing antiviral therapeutics for human diseases. Cocrystal Discovery has breakthrough technologies that enable the creation of first- and best-in-class antivirals.

LEVI & KORSINSKY, LLP Notifies Investors of BIOZONE PHARMACEUTICALS, INC. of Claims of Breaches of Fiduciary Duty by Board of the Company in Connection with the Sale of Assets to MusclePharm Corporation
Business Wire - Tue Nov 19, 12:11PM CST
Levi & Korsinsky notifies investors of Biozone Pharmaceuticals, Inc. ("Biozone" or the "Company") (Nasdaq: BZNE) of possible breaches of fiduciary duty and other violations of state law in connection with the sale of Company assets to MusclePharm Corporation ("MusclePharm") (OTCQB: MSLP).

Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of the Biozone Pharmaceuticals, Inc. Proposed Asset Sale to MusclePharm Corporation
Business Wire - Tue Nov 19, 7:17AM CST
Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating whether the Board of Directors of Biozone Pharmaceuticals, Inc. (Nasdaq: BZNE) breached its fiduciary duties in connection with the Company's proposed sale of assets to MusclePharm Corporation (OTCQB: MSLP).

Equity Reports on BZNE, NNRX and ENIP
ACCESSWIRE - Thu Nov 14, 4:16AM CST
Biozone Pharmaceuticals Inc. (OTC:BZNE), Nutranomics Inc. (OTC:NNRX) and Endeavor IP Inc. (OTC:ENIP) have been added to our watch list.

Biozone Announces First Step in Strategic Transition
Marketwire - Wed Nov 13, 2:19PM CST
Biozone Pharmaceuticals, Inc. (OTCQB: BZNE), a manufacturer of over-the-counter (OTC) pharmaceuticals, and skin care, cosmetic and beauty products, and developer of proprietary drug delivery platforms, issued the following Letter to Shareholders from Elliot Maza, Chief Executive Officer and CFO of the company.

MusclePharm to Acquire BioZone Pharmaceuticals' QuSomes(R) Technology and Manufacturing Facilities
Marketwire - Wed Nov 13, 7:03AM CST
MusclePharm Corporation (OTCQB: MSLP) ("MusclePharm"), a leading international, award-winning sports nutrition company, announced today it has signed a definitive asset purchase agreement with BioZone Pharmaceuticals, Inc. ("BioZone") to acquire substantially all of the assets of BioZone and its subsidiaries.

Today's Equity Reports on BZNE, ARIA, AXPW and SPDL
ACCESSWIRE - Mon Nov 04, 1:25AM CST
Biozone Pharmaceuticals, (OTC: BZNE), ARIAD Pharmaceuticals Inc. (NASDAQ: ARIA), Axion Power International, Inc. (OTC: AXPW) and Spindle, Inc (OTC: SPDL) have been added to our watch list.

Cocrystal Pharma, Inc. (COCP) Stock Research Links

COCP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Job Market Shifts: Adaptation vs. Fairness Dilemma

Updated Category News Views 2

The Chameleon Effect in Today's Job Market Walk into any open-space office these days, and you'll see faces plastered with composed, work-ready smiles—faces that might not look so familiar outside those walls. The modern workplace has draped its cloak over individual personalities, with the mighty pressure to 'fit in' often forcing a change in how folks present...

Continue Reading
Wave Kids™ Unveils New Flavors for Kids' Drinks

Updated Category News Views 1

Sparking a Fresh Wave in the Kids' Beverage Market Alright, let me tell you about a new player plowing into the kids' drink scene. Wave Kids™, a brand that's making waves—pun intended—has a fresh lineup that screams 'fun' and 'healthy' in equal measure. Just coinciding with back-to-school season, this Scottsdale, Arizona outfit has rolled out not one or two, but...

Continue Reading
LeoLabs and SciTec Partner for $93.7M Space Force Deal

Updated Category News Views 1

LeoLabs and SciTec Join Forces for Space Dominance The space race ain't just about rockets blasting off anymore. It's about making sure we've got eyes everywhere, even on the back of our heads, so to speak. Enter LeoLabs teaming up with SciTec to help the U.S. Space Force upgrade their radar systems to something out of a sci-fi flick, armed with a $93.7 million contract...

Continue Reading
Agroz's Big Leap: New Supply Deal in Malaysia

Updated Category News Views 1

Agroz Inc. Executes a Game-Changing Deal If anyone thought the ag tech players were sitting idle, think again. Agroz Inc., noted for their innovative controlled-environment agriculture, just inked a pivotal deal with Harvest Hive in Malaysia. It's not just a nod to expansion—it's a strategic leap into the big leagues. Picture this: Harvest Hive's sprawling 500-acre farm...

Continue Reading
Hanover Unveils Skinny Veg® for GLP-1 Dieters

Updated Category News Views 4

Seems like Hanover Foods is turning heads with their move into the ever-demanding health-conscious market. This family's stepping into the limelight with their new Skinny Veg® line, clearly targeting folks riding the GLP-1 wave. You see, it's not every day that a company that's been around the block since 1924 shakes things up like this. Simplicity is the Name of the...

Continue Reading
Goodwill's ReThink Fashion: Textiles to Runway Art

Updated Category News Views 3

Transforming Old to New on the Runway Right when you think fashion's all about the next shiny thing, here comes Goodwill of Delaware & Delaware County flipping the script. Their ReThink Fashion Show - the ECO Edit teaches us a thing or two about what giving old clothes a new life truly means. It's not just about tossing a used tee onto a catwalk but a whole rebirth...

Continue Reading
ABC Honors 2026 Spirit of the Heart Leaders

Updated Category News Views 2

Celebrating Champions of Cardiovascular Health In a world where accolades often feel as cold as the stock market after a crash, it’s heartening to see genuine recognition for those who are making actual, lasting impact. On October 3, 2026, the Association of Black Cardiologists (ABC) will hold its annual Spirit of the Heart Awards at none other than Cipriani Wall...

Continue Reading
Alif Semiconductor Unveils StartKit for Edge AI MCU Fam

Updated Category News Views 3

Here's some clarity amidst the storm of buzzwords: Alif Semiconductor has rolled out something the market's been howling for—Edge AI that doesn't break the bank. It's less about slick press releases and more about real-world implications. We're talking accessibility with their dirt-cheap, small-form-factor StartKit platform for Ensemble and Balletto microcontrollers....

Continue Reading
RevSystems Joins Elite OpenAI Partner Network

Updated Category News Views 0

RevSystems Inks Deal with OpenAI Partner Network In the latest shuffle of the AI advisory deck, RevSystems just found itself elbowing into the exclusive OpenAI Partner Network. Based out of New York, RevSystems has carved a niche by spinning tech wizardry into tangible business results. Their new status as an OpenAI Select Partner puts them on a playing field where AI...

Continue Reading
MCatalysis Secures $5M to Disrupt Fuel Cost Dynamics

Updated Category News Views 1

Funding Fuels Innovation MCatalysis has just secured a hefty $5 million in seed funding to throw down with the big dogs in energy production. This isn't your regular backyard science project; this company is serious about changing the game with a tech-driven approach that could undercut current fuel prices. HL Energy Ventures and Oxford Science Enterprises are backing...

Continue Reading

Top 5 Most Recently Viewed Articles

Hesai Group Q2 2024 Financial Results Overview

Updated Category News Views 97

Hesai Group Reports Second Quarter 2024 Unaudited Financial Results For the second quarter of 2024, Hesai Group recorded net revenues of RMB458.9 million (US$63.1 million) and shipped a total of 86,526 lidar units. Today, Hesai Group (NASDAQ: HSAI), a global leader in three-dimensional light detection and ranging (lidar) solutions, announced its unaudited financial...

Continue Reading
Optimove's Growth Strategy: Doubling iGaming Clientele Ahead

Updated Category News Views 218

Optimove's Strategy to Expand New iGaming Clients in 2025 Optimove, the pioneering force behind Positionless Marketing and a leader in Player Engagement Platforms for iGaming, is set on a remarkable trajectory towards unprecedented growth. The company recently celebrated significant success, projecting to more than double its base of new iGaming clients in just one year....

Continue Reading
One Liberty Properties Celebrates 132nd Dividend Milestone

Updated Category News Views 154

Celebrating 33 Years of Consistent Dividends One Liberty Properties, Inc. (NYSE: OLP) proudly announces the declaration of a quarterly dividend of $0.45 per share on its common stock. This news is not just a financial update; it marks a significant milestone in the company's history of maintaining dividends, celebrating 33 consecutive years of either increasing or...

Continue Reading
Investors Urged to Act: BioAge Labs Faces Lawsuit Threat

Updated Category News Views 112

Understanding the BioAge Labs Lawsuit Investors in BioAge Labs, Inc. are currently facing a significant legal challenge with a lawsuit that has been initiated against the company and its senior executives. This legal action raises critical concerns about various securities law violations, prompting many investors to seek clarity on their rights and options. If you're...

Continue Reading
Jasper Therapeutics Investors: Join Class Action Lawsuit Today

Updated Category News Views 357

Opportunity for Jasper Therapeutics Investors Investors in Jasper Therapeutics, Inc. are presented with a significant opportunity as a class action lawsuit unfolds concerning potential securities fraud. This class action is spearheaded by Rosen Law Firm, a respected entity in investor rights law, representing those who purchased securities of Jasper Therapeutics, Inc....

Continue Reading